Funded Startups in Vlaams-Brabant
Among the 36 listed Vlaams-Brabant rounds, Coultreon Biopharma’s $125M (Series A) on 2026-04-28 is the largest disclosed amount and it sits far above the r…
Among the 36 listed Vlaams-Brabant rounds, Coultreon Biopharma’s $125M (Series A) on 2026-04-28 is the largest disclosed amount and it sits far above the rest of the disclosed figures. The next-largest disclosed rounds include Augustine Therapeutics at $84M (2025-03-24) and miDiagnostics at $32M (2024-12-04), underscoring how one biotech raise dwarfs typical check sizes in this slice.
Date-wise, activity clusters tightly in late spring 2026: multiple disclosed rounds land from 2026-04-28 back through 2026-05-12 (e.g., Coultreon Biopharma $125M on 2026-04-28; neuroClues $12M on 2026-04-06; Ventory $3M on 2026-05-12; ReVision Implant $5M on 2026-05-26). Sector concentration also appears: Biotechnology shows up repeatedly (Coultreon Biopharma 2026-04-28, neuroClues 2026-04-06, Trince 2026-01-20, and others), while “Series Unknown” appears in several entries and “undisclosed” appears as a disclosed-amount placeholder on multiple rows. The window spans 2020-03-11 (THEOplayer) through 2026-06-16 (Astracite).
Most recent rounds
36 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Vlaams-Brabant list, and how extreme is it versus the next-largest disclosed amounts?
Coultreon Biopharma’s $125M (Series A) on 2026-04-28 is the only disclosed figure above $100M in these rows. The next-largest disclosed amounts are $84M for Augustine Therapeutics (2025-03-24) and $32M for miDiagnostics (2024-12-04), making Coultreon’s round a clear outlier.
Do the most recent rounds cluster in a narrow time window, or are they evenly spread across years?
They cluster near late spring 2026: disclosed rounds appear on 2026-04-06 (neuroClues $12M), 2026-04-28 (Coultreon Biopharma $125M), 2026-05-12 (Ventory $3M), and 2026-05-26 (ReVision Implant $5M). The list otherwise stretches back to 2020-03-11 (THEOplayer $10M), indicating a heavier concentration in the most recent period.
Which cities show up repeatedly, suggesting a geographic pattern within Vlaams-Brabant?
Leuven is the most recurrent city in the disclosed rows (e.g., Astracite in Heverlee; Runeasi, Swave Photonics, Augustine Therapeutics, and others list Leuven as the location). Heverlee also appears more than once (Astracite 2026-06-16 $870K; Coultreon Biopharma 2026-04-28 $125M; Pharrowtech 2024-07-24 $5M), hinting at an inner-region concentration rather than a single-point spread.
How much of the dataset is missing a clear round size or round classification (Series Unknown vs undisclosed)?
Several entries omit amounts (“undisclosed”) such as Novobiom (2026-02-23), Guardsquare (2025-07-03), and SettleMint (2024-12-10). “Series Unknown” also appears repeatedly across the 2026–2024 entries (e.g., ReVision Implant 2026-05-26 $5M; Orion Intelligence 2026-05-19 $550K; Trince 2026-01-20 $6M), limiting stage comparisons for a portion of the list.
Is there a sector tilt in this tranche, or are raises evenly distributed across industries?
Biotechnology is the most visible repeat sector, including Coultreon Biopharma (2026-04-28 $125M), neuroClues (2026-04-06 $12M), Trince (2026-01-20 $6M), and Paleo (2024-10-31 undisclosed). Artificial Intelligence (AI) also recurs (e.g., Orion Intelligence 2026-05-19 $550K; Ventory 2026-05-12 $3M; LynxCare 2022-06-21 $21M), but the largest disclosed outlier in this slice is biotech.
Which stage labels show up often enough to matter for sales or diligence planning (ignoring Series Unknown)?
Beyond “Series Unknown,” multiple entries carry named stages such as Series A (Coultreon Biopharma 2026-04-28 $125M; neuroClues 2026-04-06 $12M; Swave Photonics 2025-06-25 $7M) and Seed (e.g., Runeasi 2026-02-04 $1M; xyzt.ai 2023-10-23 $1M; ASKA 2022-03-17 $1M). Pre-Seed also appears more than once (Astracite 2026-06-16 $870K; Forcebit 2024-09-09 $300K), suggesting a pipeline that includes both early and scaled biotech rounds.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.